Effects of cypermethrin on the dopaminergic neurons in the progressive hemiparkinsonian rats

Toxicology Mechanisms and Methods

Volumn 15, Issue 6, 2005, Pages 399-404

  Mun, Ji Young ^a   Won, Yong Lee ^b   Sung, Sik Han ^a  

^a Korea University   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CIPERMETHRIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DELAYED NEUROTOXICITY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; ENZYME ACTIVITY; FOREFOOT; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL DEGENERATION; NERVE CELL NECROSIS; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; RAT; SPECIES COMPARISON; SUBSTANTIA NIGRA;

ANIMALIA; CHRYSANTHEMUM;

EID: 30744441167     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.1080/15376520500194742     Document Type: Article

References (40)

1. Aldridge, W. N. 1990. An assessment of the toxicological properties of pyrethroids and their neurotoxicity. Crit. Rev. Toxicol. 21:89-104.
2. Barbeau, A., Roy, M., and Bernier, G. 1987. Ecogenetics of Parkinson's disease:prevalence and environmental aspects in rural areas. Can. J. Neurol. Sci. 14:36-41.
3. Beate, R., and Fei, Y. 2000. Parkinson's disease mortality and pesticide exposure in California 1984-1994. Int. J. Epidemiol. 29:323-329.
4. B ernheimer, H., Birkmayer, W., and Hornykiewicz, O. 1973. Brain dopamine and the syndromes of Parkinson and Huntington: Clinical, morphological, and neurochemical correlations. J. Neurol. Sci. 20:415-455.
5. Betarbet, R., Sherer, T. B., Macenzie, G., Garcia-Osuna, M., Panov, A. V., and Greenamyre, J.T. 2000. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3:1301-1306.
6. Bocchetta, A., and Corsini, G. U. 1986. Parkinson's disease and pesticides. Lancet 2:1163.
7. Cantalamessa, F., Barili, P., Cavagna, R., Sabbatini, M., Tenore, G., and Amenta, F. 1998. Influence of neonatal treatment with the pyrethroid insecticide cypermethrin on the development of dopamine receptors in the rat kidney. Mech. Ageing Dev. 103:165-178.
8. Chang, J. W., Wachtel, S. R., Young, D., and Kang, U. J. 1999. Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson's disease:studies on medial forebrain bundle striatal lesions. Neuroscience. 88:617-628.
9. Condes-Lara, M., Graff-Guerrero, A., and Vega-Riveroll, L. 1999. Effects of cypermethrin on the electroencephalographic activity of the rat: A model of chemically induced seizures. Neurotoxicol. Teratol. 21:293-298.
10. Crawford, M. J., Croucher, A., and Hutson, D. H. 1981. Metabolism of cis- and trans-cypermethrin in rats. Balance and tissue retention study. J. Agric. Food Chem. 29:130-135.
11. Dwight, C. German., Kebreten F. Manaye. 1993. Midbrain dopaminergic neurons (nuclei A8, A9 and A10):three-dimensional reconstruction in the rat. J. Comp. Neurol. 331:297-309.
12. Giray, B., Gurbay, A., and Hincal, F. 2001. Cypermethrin-induced oxidative stress in rat brain and liver is prevented by vitamin E or allopurinol. Toxicol. Lett. 118:139-16.
13. Gupta, A., Nigam, D., Gupta, A., Shukla, G. S., and Agarwal, A. K. 1999. Effect of pyrethroid-based liquid mosquito repellent inhalation on the blood-brain barrier function and oxidative damage in selected organs of developing rats. J. Appl. Toxicol. 19:67-72.
14. Hall, S., Rutledge, J. N., and Schallert, T. 1992. MRI, brain iron and experimental Parkinson's disease. J. Neurol. Sci. 113:198-208.
15. Hayes, W. J., and Laws, E. R. 1991. Handbook of Pesticide Toxicology. New York: Academic Press.
16. Hirsch, E. C., Faucheux, B., Damier, P., Mouatt-Prigent, A., and Agid, Y. 1997. Neuronal vulnerability in Parkinson's disease. J. Neural. Transm. 50:79-88.
17. Hubble, J. P., Hassanein, R.E.S., Neuberger, J. S., and Koller, W. C. 1993. Risk factors for Parkinson's disease. Neurology 43:1693-1697.
18. Hornykiewicz, O., and Kish, S. J. 1986. Biochemical pathophysiology of Parkinson's disease. Adv. Neurol. 45:19-34.
19. Jenner, P., Schapira, A. H., and Marsden, C. D. 1992. New insights into the cause of Parkinson's disease. Neurology 42:2241-2250.
20. Kale, M., Rathore, N., John, S., and Bhatnagar, D. 1999. Lipid peroxidative damage on pyrethroid exposure and alterations in antioxidant status in rat erythrocytes: A possible involvement of reactive oxygen species. Toxicol. Lett. 105:197-205.
21. Kirik, D., Georgievska, B., Burger, C., Winkler, C., Muzyczka, N., Mandel, R. J., and Björklund, A. 2002. Reversal of motor impairments in parkinsonian rats by continuous intrastriatal delivery of L-dopa using rAAV-mediated gene transfer. Proc. Natl. Acad. Sci. USA. 99:4708-4713.
22. Koller, W., Vetere Overfield, B., and Gray, C. 1990. Environmental risk factors in Parkinson's disease. Neurology 40:1218-1221.
23. Kostrzewa, R. M., and Jacobowiz, D. M. 1974. Pharmacological actions of 6-hydroxydopamine. Pharmacol. Rev. 26:199-288.
24. Kumar, R., Agarwal, M. L., and Seth, P. K. 1995. Free radical-generated neurotoxicity of 6-hydroxydopamine. J. Neurochem. 64:1703-1707.
25. Lee, C. S., Sauer, H., and Björklund, A. 1996. Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by intrastriatal 6-hydroxydopamine in the rat. Neuroscience 72:641-653.
26. Lee, E. A., Lee, W. Y., Kim, Y. S., and Kang, U. J. 2003. The effects of chronic L-DOPA therapy on pharmacodynamic parameters in a rat model of motor response fluctuations. Exp. Neurol. 33:93-98.
27. Lee, W. Y., Kim, G. M., and Lee, J. I. 2000. The behavioral changes and the patterns of dopamine neuronal degeneration after instrastriatal 6-hydroxydopamne injection in rat. Korean Neurolog. Assoc. 18:741-747.
28. Malaviya, M., Husain, R., and Seth, P. K. 1993. Perinatal effects of two pyrethroid insecticides on brain neurotransmitter function in the neonatal rat. Vet. Human Toxicol. 35:119-122.
29. Narahashi, T., Frey, J. M., Ginsburg, K.S., and Roy, M. L. 1992. Sodium and GABA-activated channels as the targets of pyrethroids and cyclodienes. Toxicol. Lett. 64:429-436.
30. Olsson, M. Nikkahh, G., Bentlage, C., and Björklund, A. 1995. Forelimb akinesia in the rat Parkinson model: Differential effects of dopamine agonist and nigral transplants as assessed by a new stepping test. J. Neurosci. 15:3863-3875.
31. Paxinos, G., and Watson, C. 1998. The Rat Brain in Stereotaxic Coordinates (4th ed). San Diego: Academic press Inc.
32. Przedborski, S., Levivier, M., Jiang, H., Ferreira, M., Jackson-Lewis, V., Donaldson, S., and Togasaki, D. M. 1995. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine. Neuroscience 67:631-647.
33. Rosner, B. 1995. Fundamentals of Biostatics, (4th ed.) pp. 314-315. Belmont: Duxbury Press.
34. Rios, C., and Tapia, R., 1987. Changes in lipid peroxidation induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium in mouse brain homogenates. Neurosci. Lett. 77:321-326.
35. Sauer, H., and Oertel, W. H. 1994. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: A combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 50:401-415.
36. Semchuk, K. M., Love, E.J., and Lee, R. G. 1992. Parkinson's disease and exposure to agricultural work and pesticide chemicals. Neurology 42:1328-1335.
37. Semchuk, K. M., Love, E. J., and Lee, R. G. 1993. Parkinson's disease:a test of the multifactorial etiologic hypothesis. Neurology 43:1173-1180.
38. Sian, J., Dexter, D. T., Lees, A. J., Daniel, S., Jenner, P., and Marsden, C. D. 1994. Glutathione-related enzymes in brain in Parkinson's disease. Ann. Neurol. 36:356-361.
39. Towle, A. C., Lauder, J. M., and Joh, T. H. 1984. Optimization of tyrosine hydroxylase immunocytochemistry in paraffin sections using pretreatment with proteolytic enzymes. J. Histochem. Cytochem. 32:766-770.
40. Ungerstedt, U. 1968. 6-Hydroxydopamine induced degeneration of central monoamine neurons. Eur. J. Pharmacol. 5:107-110.